05.06.2014 • News

Solvay Completes Sale of European PVC Compounding

Folllowing approval by the European Commission, Solvay has completed the sale of its PVC compounding business, Benvic Europe, to US private equity investor OpenGate Capital.

The deal announced in April sees the transfer of the Belgian compounder with annual sales of €160 million and three production sites in France, Italy and Spain.

OpenGate previously acquired the France-based Kem One PVC polymerization business from Swiss-based Klesch Group business and the profile extrusion activities of another Belgian PVC specialist, Tessenderlo.

OpenGate said earlier the two acquisitions will have compounding capacity of 200,000 t/y. Profialis last reported sales of €80 million.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.